课题基金 / 基金详情

项目摘要

项目成果

TARUN M. KAPOOR的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract: Our long-term goal is to decipher the molecular mechanisms that ensure the proper assembly and function of the microtubule-based structures needed for error-free cell division. Essentially all the proteins required for cell division in human cells have now been identified. However, uncovering mechanisms has remained challenging as cell division is rapid and can be completed in <1 hour in human cells, with key steps taking only minutes. In addition, the microtubule-based structures needed for cell division require constant energy input to maintain shape and size, cannot be readily isolated in native forms and the protein-protein interactions critical for function can be transient and mitosis-specific. Finally, these structures are micrometer-sized and can be ~1000-times larger than their protein components. We take interdisciplinary approaches that can address these challenges and help dissect the dynamic self-assembly of these essential structures. We have: (i) Discovered and characterized selective cell-permeable chemical inhibitors of key proteins. These inhibitors can be powerful probes to examine cell division dynamics, as proteins can be inhibited or activated (via relief from inhibition), within minutes in living cells. To track the cellular responses to these fast perturbations we use state-of-the-art microscopy (e.g. lattice light-sheet microscopy) and quantitative image analysis methods. (ii) Developed and applied iCLASPI, a chemical proteomics approach to covalently ‘capture’ and profile transient and context-dependent protein-protein interactions in living cells. (iii) Analyzed the self-assembly of basic structural and functional motifs (e.g. bipolar microtubule arrays) with purified proteins. For these biochemical studies, we have assembled a ‘toolbox’ of recombinant proteins including isotypically-pure human tubulin, the augmin complex and key microtubule- associated motor and non-motor proteins. The proposed research, which benefits from our experience and expertise, will focus on anaphase and cytokinesis. These final stages of cell division can be difficult to study using approaches that cannot profile transient protein-protein interactions or do not provide precise temporal control over protein function. We will take interdisciplinary approaches to address the following gaps in our knowledge: (1) What are the roles of microtubule-severing proteins during the final stages of cell division? (2) How do PRC1, a non-motor protein that selectively crosslinks antiparallel microtubules, and kinesin-4, a microtubule plus-end directed motor protein, contribute to the assembly of the spindle midzone during anaphase? (3) What are the minimum number of proteins needed for microtubule-dependent microtubule formation, a key centrosome-independent microtubule nucleation pathway needed for cell division? Errors in cell division have been linked to diseases and developmental defects. Improper cell division has also been exploited in therapeutic strategies commonly used to treat diseases, such as cancer. Our work will not only shed light on fundamental cellular mechanisms but will also catalyze the development of new therapeutics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Chemical Biology of Cell Division - Revision - 2
  • 批准号:
    10578031
  • 项目类别:
  • 资助金额:
    $10.34万
  • 财政年份:
    2019
  • 负责人:
    TARUN M. KAPOOR
  • 依托单位:
Chemical Biology of Cell Division
  • 批准号:
    10565682
  • 项目类别:
  • 资助金额:
    $72.23万
  • 财政年份:
    2019
  • 负责人:
    TARUN M. KAPOOR
  • 依托单位:
Chemical Biology of Cell Division
  • 批准号:
    10090616
  • 项目类别:
  • 资助金额:
    $72.23万
  • 财政年份:
    2019
  • 负责人:
    TARUN M. KAPOOR
  • 依托单位:
Studying chromosome function using chemical biology
  • 批准号:
    8332754
  • 项目类别:
  • 资助金额:
    $37.71万
  • 财政年份:
    2011
  • 负责人:
    TARUN M. KAPOOR
  • 依托单位:
国内基金
海外基金
RIF1蛋白在处理超细后期桥(ultrafine anaphase bridge)和保障基因组稳定的作用
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2019
  • 负责人:
    陈英伟
  • 依托单位: